Deimmunized antibodies specific for cd3
US-2025206819-A1 · Jun 26, 2025 · US
This page is not indexed by search engines while we improve data quality.
Bültmann Andreas patents
Bültmann Andreas is listed as an inventor on 11 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bültmann Andreas |
| Total patents | 11 |
| First publication | Feb 28, 2019 |
| Latest publication | Jun 26, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Novel human antibodies binding to human cd3 epsilon
US-2023357398-A1 · Nov 9, 2023 · US
Humanized antibodies for CD3
US-11472880-B2 · Oct 18, 2022 · US
Multispecific antigen-binding molecules
US-2022041719-A1 · Feb 10, 2022 · US
Polypeptide library
US-11085038-B2 · Aug 10, 2021 · US
Humanized antibodies for cd3
US-2020377594-A1 · Dec 3, 2020 · US
Antagonists of IL17C for the treatment of inflammatory disorders
US-10815297-B2 · Oct 27, 2020 · US
Polypeptide library
US-2020231963-A1 · Jul 23, 2020 · US
Polypeptide library
US-10655125-B2 · May 19, 2020 · US
Polypeptide library
US-2019270981-A1 · Sep 5, 2019 · US
Recent patents
Latest publications not already listed above.
Antagonists of il17c for the treatment of inflammatory disorders
US-2019062422-A1 · Feb 28, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Morphosys Ag | 11 |
| Galapagos Nv | 1 |
| Galapagos Nv | 1 |
| Mor0059Us Np | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/55 | 7 |
| C07K2317/92 | 7 |
| C07K2317/33 | 6 |
| C07K16/2809 | 5 |
| C07K2317/31 | 5 |